After the National Pharmaceutical Pricing Authority (NPPA) stating that the annual change in Wholesale Price Index (WPI) works out as 10.76 per cent, the prices of about 800 essential medicines such as paracetamol, azithromycin and ciprofloxacin hydrochloride are likely to see a sharp rise. “Based on the WPI (Wholesale Price Index) data provided by the office of the Economic Advisor, Ministry of Commerce and Industry, the annual change in WPI works out as 10.76607 per cent during the calendar year 2021 over the corresponding period in 2020,” the NPPA notice said.
Following this, the prices of over 800 scheduled medicines on the National List of Essential Medicines, used to treat fever, infections, skin diseases, high blood pressure, anaemia and heart diseases, are expected to rise 10.7 per cent from April 1.
“This is brought to the notice of all concerned for further action as per the provisions of Drugs (Price Control) Order, 2013,” it added. The Authority announces the change in WPI every year, in accordance with The Drugs (Price Control) Order, 2013, or DPCO, 2013.
The National List of Essential Medicines (NLEM), for which the NPPA is empowered to fix the ceiling price, includes common drugs and medical devices such as paracetamol tablets, azithromycin tablets, oral rehydration salts, glucose injections and contraceptives like copper IUDs and condoms. It also contains insulin injections, Vitamin C tablets and multivitamin tablets.
Last year, the National Pharmaceutical Pricing Authority had announced an increase of 0.53 per cent in Wholesale Price Index, as compared with 1.88 per cent in 2020. In 2019 and 2018, it was 4.26 per cent and 3.43 per cent, respectively.
In October 2021, the drug price regulator had fixed the ceiling prices for 12 anti-diabetic generic medicines, including glimepiride tablets, glucose injection and intermediate acting insulin solution. In a tweet, the NPPA had said, “To make it possible for every Indian to afford medical treatment against diseases like diabetes, NPPA has initiated a successful step by fixing the ceiling prices of 12 anti-diabetic generic medicines.”
As part of this, the ceiling price of metformin immediate release tablet of strength 500 mg was fixed at Rs 1.51 per tablet, while that of 750 mg strength is at Rs 3.05 per tablet and 1,000 mg strength at Rs 3.61 per tablet.
For metformin control release tablet of strength 1000 mg, the ceiling price was fixed at Rs 3.66 per tablet, said the NPPA. It added that the same for 750 mg strength was capped at Rs 2.4 per tablet and Rs 1.92 per tablet for metformin control release tablet of strength 500 mg.
The price for glimepiride tablet of strength 1 mg was fixed at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet.
Read all the Latest Business News and Breaking News here
Comments
0 comment